Participation du SAKK au congrès de l’European Society for Medical Oncology (ESMO) 2020

Le congrès 2020 de l’ESMO, qui se tiendra du 19 au 21 septembre 2020, sera l’occasion pour le SAKK de présenter certaines de ses études, à savoir:

Participation du SAKK au congrès de l’European Society for Medical Oncology (ESMO) 2020

Le congrès 2020 de l’ESMO, qui se tiendra du 19 au 21 septembre 2020, sera l’occasion pour le SAKK de présenter certaines de ses études, à savoir:

 

  • Poster   Hess D. et al. SAKK 65/16: TLD-1, a novel liposomal doxorubicin, in patients (pts) with advanced solid tumors: dose escalation part of a multicenter open-label phase I trial.

Hess

 

 

  • Oral presentation   Joerger M. et al. SAKK 80/20: Outcome and prognostic factors of SARS CoV-2 infection in cancer patients: A cross-sectional study.

Joerger

 

 

  • Poster   Früh M. et al. SAKK 19/16: Binimetinib, pemetrexed (Pem) and cisplatin (Cis), followed by maintenance of Binimetinib and Pem in patients with advanced non-small cell lung cancer (NSCLC) and KRAS mutations. The phase 1B SAKK 19/16 trial. Speaker: Patrizia Froesch.

Früh  Froesch

 

 

  • Oral presentation   Rothschild S. et al. SAKK 16/14: Anti-PD-L1 antibody durvalumab in addition to neoadjuvant chemotherapy in patients with stage IIIA(N2) non-small cell lung cancer (NSCLC) — A multicenter single-arm phase II trial.  

Rothschild

 

 

  • Poster   Ribi K. et al. SAKK 95/16: Quality of life and pain in patients with metastatic bone disease from solid tumors treated with bone-targeted agents– a real-world cross-sectional study from Switzerland.

Ribi

 

 

  • Poster   Stenner F. et al. SAKK 07/17: Optimizing Ipilimumab in RCC - Results from the SAKK 07/17 Nivolumab (N) + Ipilimumab (I) in mRCC.

Stenner

 

 

  • Poster   Hasler-Strub U. et al. SAKK 25/14: Optimal Dose of Eribulin as 1st Line Treatment in Elderly Patients ≥ 70 Years with Advanced Breast Cancer: A Multicenter Phase II Trial.

Hasler

 

Pour de plus amples d'informations, veuillez consulter le site internet de l'ESMO.

Toutes les actualités